1. Home
  2. ILMN vs ULS Comparison

ILMN vs ULS Comparison

Compare ILMN & ULS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ULS
  • Stock Information
  • Founded
  • ILMN 1998
  • ULS 1894
  • Country
  • ILMN United States
  • ULS United States
  • Employees
  • ILMN N/A
  • ULS N/A
  • Industry
  • ILMN Medical Specialities
  • ULS
  • Sector
  • ILMN Health Care
  • ULS
  • Exchange
  • ILMN Nasdaq
  • ULS Nasdaq
  • Market Cap
  • ILMN 16.0B
  • ULS 14.6B
  • IPO Year
  • ILMN 2000
  • ULS 2024
  • Fundamental
  • Price
  • ILMN $97.68
  • ULS $63.44
  • Analyst Decision
  • ILMN Buy
  • ULS Buy
  • Analyst Count
  • ILMN 15
  • ULS 8
  • Target Price
  • ILMN $123.67
  • ULS $69.25
  • AVG Volume (30 Days)
  • ILMN 1.4M
  • ULS 927.8K
  • Earning Date
  • ILMN 11-03-2025
  • ULS 11-04-2025
  • Dividend Yield
  • ILMN N/A
  • ULS 0.82%
  • EPS Growth
  • ILMN N/A
  • ULS 21.42
  • EPS
  • ILMN 7.91
  • ULS 1.62
  • Revenue
  • ILMN $4,284,000,000.00
  • ULS $2,951,000,000.00
  • Revenue This Year
  • ILMN N/A
  • ULS $6.69
  • Revenue Next Year
  • ILMN $2.76
  • ULS $6.24
  • P/E Ratio
  • ILMN $12.29
  • ULS $39.10
  • Revenue Growth
  • ILMN N/A
  • ULS 6.92
  • 52 Week Low
  • ILMN $68.70
  • ULS $46.79
  • 52 Week High
  • ILMN $156.66
  • ULS $74.15
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 47.14
  • ULS 39.70
  • Support Level
  • ILMN $95.44
  • ULS $62.20
  • Resistance Level
  • ILMN $100.44
  • ULS $64.44
  • Average True Range (ATR)
  • ILMN 2.48
  • ULS 1.44
  • MACD
  • ILMN -0.41
  • ULS -0.10
  • Stochastic Oscillator
  • ILMN 38.49
  • ULS 23.29

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ULS UL Solutions Inc.

UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.

Share on Social Networks: